Your browser doesn't support javascript.
loading
A Novel HER2-Selective Kinase Inhibitor Is Effective in HER2 Mutant and Amplified Non-Small Cell Lung Cancer.
Son, Jieun; Jang, Jaebong; Beyett, Tyler S; Eum, Yoonji; Haikala, Heidi M; Verano, Alyssa; Lin, Mika; Hatcher, John M; Kwiatkowski, Nicholas P; Eser, Pinar Ö; Poitras, Michael J; Wang, Stephen; Xu, Man; Gokhale, Prafulla C; Cameron, Michael D; Eck, Michael J; Gray, Nathanael S; Jänne, Pasi A.
Afiliação
  • Son J; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Jang J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Beyett TS; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Eum Y; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Haikala HM; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts.
  • Verano A; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Lin M; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts.
  • Hatcher JM; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Kwiatkowski NP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Eser PÖ; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Poitras MJ; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Wang S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Xu M; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Gokhale PC; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Cameron MD; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts.
  • Eck MJ; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Gray NS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Jänne PA; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Cancer Res ; 82(8): 1633-1645, 2022 04 15.
Article em En | MEDLINE | ID: mdl-35149586
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article